- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Medicines Co/The+ Add to Watchlist
MDCO:US26.2700 USD 0.6600 2.58%
As of 14:37:59 ET on 09/02/2014.
Company Profile for Medicines Co/The (MDCO)
The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
Key Executives for Medicines Co/The (MDCO)
|Clive A MeanwellChairman/CEO||Glenn P SblendorioPresident/CFO|
|Victoria KusiakExec VP/Chief Integrity Ofcr||Brent FurseExec VP/Chief Customer Officer|
|Cornelis Heiman "Cees"Exec VP/Chief Innovation Ofcr||William B O'ConnorSenior VP/Chief Acctg Officer|
|Stephen M RodinSenior VP/Secy/General Counsel||Neera D RavindranVP:Investor Relations|